Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 4 studies | 23% ± 6% | |
hepatocyte | 4 studies | 58% ± 20% |
Insufficient scRNA-seq data for expression of FMO3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 19995.98 | 226 / 226 | 95% | 250.36 | 387 / 406 |
lung | 100% | 1991.32 | 577 / 578 | 89% | 19.87 | 1024 / 1155 |
kidney | 89% | 1348.74 | 79 / 89 | 71% | 9.99 | 638 / 901 |
adrenal gland | 95% | 650.71 | 244 / 258 | 56% | 5.49 | 128 / 230 |
breast | 98% | 718.88 | 450 / 459 | 51% | 6.58 | 571 / 1118 |
esophagus | 96% | 394.05 | 1384 / 1445 | 50% | 3.05 | 91 / 183 |
pancreas | 60% | 154.43 | 198 / 328 | 78% | 5.74 | 138 / 178 |
stomach | 66% | 185.74 | 238 / 359 | 49% | 5.15 | 141 / 286 |
thymus | 87% | 288.04 | 567 / 653 | 27% | 0.98 | 161 / 605 |
adipose | 99% | 1950.01 | 1193 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 93% | 473.86 | 1241 / 1335 | 0% | 0 | 0 / 0 |
skin | 68% | 310.79 | 1237 / 1809 | 24% | 1.57 | 114 / 472 |
muscle | 80% | 240.27 | 643 / 803 | 0% | 0 | 0 / 0 |
uterus | 54% | 184.25 | 91 / 170 | 26% | 18.23 | 121 / 459 |
heart | 79% | 246.21 | 677 / 861 | 0% | 0 | 0 / 0 |
intestine | 35% | 106.59 | 342 / 966 | 29% | 1.79 | 153 / 527 |
tonsil | 0% | 0 | 0 / 0 | 62% | 37.21 | 28 / 45 |
lymph node | 0% | 0 | 0 / 0 | 55% | 1.82 | 16 / 29 |
brain | 18% | 35.37 | 463 / 2642 | 25% | 0.96 | 176 / 705 |
prostate | 38% | 94.78 | 92 / 245 | 5% | 0.13 | 24 / 502 |
bladder | 19% | 37.05 | 4 / 21 | 19% | 5.60 | 94 / 504 |
eye | 0% | 0 | 0 / 0 | 20% | 0.91 | 16 / 80 |
ovary | 6% | 16.13 | 11 / 180 | 12% | 1.91 | 50 / 430 |
peripheral blood | 5% | 25.19 | 43 / 929 | 0% | 0 | 0 / 0 |
spleen | 3% | 22.03 | 8 / 241 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0042412 | Biological process | taurine biosynthetic process |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0047822 | Molecular function | hypotaurine dehydrogenase activity |
GO_0034899 | Molecular function | trimethylamine monooxygenase activity |
GO_0050661 | Molecular function | NADP binding |
GO_0004499 | Molecular function | N,N-dimethylaniline monooxygenase activity |
GO_0050660 | Molecular function | flavin adenine dinucleotide binding |
GO_0005515 | Molecular function | protein binding |
GO_0047638 | Molecular function | albendazole monooxygenase activity |
Gene name | FMO3 |
Protein name | Flavin-containing monooxygenase 3 (EC 1.14.13.148) (EC 1.14.13.32) (EC 1.14.13.8) (Dimethylaniline monooxygenase [N-oxide-forming] 3) (Dimethylaniline oxidase 3) (FMO II) (FMO form 2) (Hepatic flavin-containing monooxygenase 3) (FMO 3) (Trimethylamine monooxygenase) Flavin-containing monooxygenase (EC 1.-.-.-) Flavin-containing monooxygenase 3 (EC 1.14.13.148) (EC 1.14.13.32) (EC 1.14.13.8) (Dimethylaniline monooxygenase [N-oxide-forming] 3) (Trimethylamine monooxygenase) |
Synonyms | |
Description | FUNCTION: Essential hepatic enzyme that catalyzes the oxygenation of a wide variety of nitrogen- and sulfur-containing compounds including drugs as well as dietary compounds . Plays an important role in the metabolism of trimethylamine (TMA), via the production of trimethylamine N-oxide (TMAO) metabolite . TMA is generated by the action of gut microbiota using dietary precursors such as choline, choline containing compounds, betaine or L-carnitine. By regulating TMAO concentration, FMO3 directly impacts both platelet responsiveness and rate of thrombus formation . . |
Accessions | P31513 V9GYP3 V9GZ60 A0A0S2Z3R0 ENST00000367755.9 ENST00000472784.5 ENST00000479749.1 A0A024R8Z4 |